RE:RE:RE:40% of tests come back to late to be helpfulMaybe the relationship between the FDA and SONA going back to 2006 when the FDA created a section for all nanotechnology and SONA had already been working on the GNRs may influence the decision. That plus the fact that if enough testing is done from the manufacturing which is going on now to prove the method and due to the pandemic, swift authorization may be invoked depending on the field test results. IMO